Search for Clinical Trial Results

Sponsored By

Epidermolysis Bullosa Dystrophica - 24 Studies Found

Status Study
Completed Study Name: Treatment of Epidermolysis Bullosa Dystrophica by Polyphenon E (Epigallocatechin 3 Gallate)
Condition: Epidermolysis Bullosa Dystrophica
Date: 2009-08-03
Interventions:
  • Drug: Polyphenon E before Placebo

Terminated Study Name: Recessive Dystrophic Epidermolysis Bullosa Screening for Possible Gene Transfer
Condition: Epidermolysis Bullosa Dystrophica
Date: 2007-09-20
Recruiting Study Name: Characteristics of Patients With Recessive Dystrophic Epidermolysis Bullosa
Condition: Epidermolysis Bullosa Dystrophica
Date: 2009-11-20
Completed Study Name: Characteristics of Adult Patients With Recessive Dystrophic Epidermolysis Bullosa
Condition: Epidermolysis Bullosa Dystrophica
Date: 2009-05-15
Recruiting Study Name: A Study of FCX-007 for Recessive Dystrophic Epidermolysis Bullosa (RDEB)
Condition: Epidermolysis Bullosa Dystrophica, Recessive
Date: 2016-06-13
Interventions:
  • Genetic: FCX-007 FCX-007 is a

Recruiting Study Name: Gene Transfer for Recessive Dystrophic Epidermolysis Bullosa
Condition:
  • Epidermolysis Bullosa Dystrophica
  • Epidermolysis Bullosa
    • Date: 2010-12-15
    Interventions: Genetic: LZRSE-Col7A1 Engineered Autologous Epidermal Sheets This trial will create a graft, which we ca
Withdrawn Study Name: Prospective, Longitudinal Natural History Study in Dystrophic Epidermolysis Bullosa
Condition: Dystrophic Epidermolysis Bullosa
Date: 2013-01-10
Completed Study Name: Treatment of Chronic and Non-Chronic Wounds in Patients With Recessive Dystrophic Epidermolysis Bullosa Using Helicoll Collagen Dressings Versus Standard of Care
Condition:
  • Epidermolysis Bullosa Dystrophica
  • Epidermolysis Bullosa
    • Date: 2012-10-25
    Interventions:
    • Device: Helicoll Helicoll Coll
Withdrawn Study Name: A Pilot Study of HP802-247 in Dystrophic Epidermolysis Bullosa
Condition: Dystrophic Epidermolysis Bullosa
Date: 2012-01-31
Interventions:
  • Biological: HP802-247

Completed Study Name: Efficacy of Granulocyte Colony Stimulating Factor (GCSF) In Patients With Dystrophic Epidermolysis Bullosa
Condition: Dystrophic Epidermolysis Bullosa
Date: 2012-02-20
Interventions: Drug: Granulocyte Colony Stimulating Factor (GCSF) G-CSF 10mcg/kg/d SQ for 7 days
Next >>>